DCGI Approves Emergency Use Of Bharat Biotech’s Covaxin For Children Aged 6-12 Years
ANI news agency, on Tuesday, reported that the Drugs Controller General of India (DCGI) has approved the emergency use authorisation for Bharat Biotech’s Covaxin for children aged 6-12 years.
The DGCI has asked vaccine manufacturers to…
Read More...
Read More...